The disclosure relates to cycloalkylene azoles of general Formula I ##STR1## wherein ##STR2## is a carbocyclic or carbopolycyclic group optionally carrying at least one alkyl substituent, X is the grouping ##STR3## an oxygen or sulfur atom, and Y and Z, independently of each other, are ##STR4## or a nitrogen atom, as well as their pharmaceutically compatible addition salts with acids as well as processes for production thereof. The compounds possess strongly aromatase-inhibiting activity and are suitable for the preparation of medicinal agents. Methods for treating estrogen induced or stimulated tumors, male infertility, and impending cardiac infarction with these compounds are also provided as well as methods for inhibiting female fertility.
该公开涉及一般式I的环烷基氮唑化合物
##STR1##其中##STR2##
是一个碳环或碳多环基团,可选择地携带至少一个烷基取代基,X是基团##STR3##一个氧或
硫原子,Y和Z彼此独立,是##STR4##或一个氮原子,以及它们与酸的药用兼容盐的生产方法。这些化合物具有强烈的芳香化酶抑制活性,并适用于制备药用剂。还提供了使用这些化合物治疗
雌激素诱导或刺激的肿瘤、男性不育和即将发生心肌梗死的方法,以及抑制女性生育的方法。